. . . . . . . . . . . "p(HGNC:CDKN1B) -| path(SDIS:\"tumor growth\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "In fact, Skp2 overexpression was shown to induce the transcription of c-Myc target genes suggesting that Skp2 acts as a transcription coactivator of c-Myc. Skp2 can concurrently lead to degradation of tumor suppressors (p27, p57, p21 and p130) and to activation of an oncogene (c-Myc). While Skp2-deficient mice, which should have decreased c-Myc activity, can develop almost normally" . . "Selventa" . . . . "2014-07-03T14:30:21.387+02:00"^^ . . .